U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07003581) titled 'Cardiometabolic Risk Factors Associated With Multidrug-Resistant Tuberculosis' on May 26.
Brief Summary: Background: MDR-TB remains a major public health concern, especially in high-burden countries like Nepal. While individual risk factors are known, the cumulative impact of cardiometabolic on MDR-TB is not well understood.
Methods and Findings: A health-facility-based, age- and sex-matched 1:2 case-control study will be conducted at DR-TB treatment centers in Gandaki Province, Nepal. MDR-TB patients (cases) and DS-TB patients (controls) will be enrolled. Cases will be defined as adults (>=18 years) with confirmed MDR-TB; controls ...